Brand Banner 468x60

FEATURED ARTICLE

 

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

PR Newswire  2018-01-13 02:30:00

ST. CHARLES, Mo., Jan. 12, 2018 /PRNewswire/ -- Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule anticancer agent technology, announced today that it has been awarded a Small Business Innovation...

Full Story »

Comments

No Comments
Your name: *
Email:
Comment: *
 
Share
submit to reddit
Save On Airport Parking